High ERβ expression is associated with improved survival on tamoxifen in breast cancer

被引：0
|
作者：
Witton, CJ
Tovey, SM
Cooke, TG
Dunne, B
Bartlett, JM
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] DakoCytomation AS, Copenhagen, Denmark
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S244 / S245
页数：2
相关论文
共 50 条
  • [1] High UTX expression is associated with tamoxifen resistance in luminal A breast cancer
    Kim, Dong-Hoon
    Min, Kyueng-Whan
    Chae, Seoung Wan
    Do, Sung-Im
    Oh, Young-Ha
    Son, Byoung Kwan
    [J]. MODERN PATHOLOGY, 2019, 32
  • [2] High UTX expression is associated with tamoxifen resistance in luminal A breast cancer
    Kim, Dong-Hoon
    Min, Kyueng-Whan
    Chae, Seoung Wan
    Do, Sung-Im
    Oh, Young-Ha
    Son, Byoung Kwan
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [3] High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
    Paulsson, Janna
    Ryden, Lisa
    Strell, Carina
    Frings, Oliver
    Tobin, Nicholas P.
    Fornander, Tommy
    Bergh, Jonas
    Landberg, Goran
    Stal, Olle
    Ostman, Arne
    [J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2017, 3 (01): : 38 - 43
  • [4] High miR-143 is associated with improved survival for ER positive breast cancer patients by targeting KRAS signaling
    Tokumaru, Yoshihisa
    Futamura, Manabu
    Mori, Ryutaro
    Matsuhashi, Nobuhisa
    Yoshida, Kazuhiro
    [J]. CANCER SCIENCE, 2022, 113 : 1529 - 1529
  • [5] High HMGN5 expression confers resistance to tamoxifen and its expression is predictive of response to tamoxifen in ER plus breast cancer patients
    Elias, D.
    Suntharalingam, L.
    Vever, H.
    Lykkesfeldt, A.
    Bak, M.
    Ditzel, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S197 - S197
  • [6] High IKK expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer
    Bennett, Lindsay
    Quinn, Jean
    McCall, Pamela
    Mallon, Elizabeth A.
    Horgan, Paul G.
    McMillan, Donald C.
    Paul, Andrew
    Edwards, Joanne
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (07) : 1633 - 1644
  • [7] Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma
    Gruvberger-Saal, Sofia K.
    Bendahl, Paer-Ola
    Saal, Lao H.
    Laakso, Mervi
    Hegardt, Cecilia
    Eden, Patrik
    Peterson, Carsten
    Malmstroem, Per
    Isola, Jorma
    Borg, Ake
    Fernoe, Marten
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1987 - 1994
  • [8] Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
    E. A. Reijm
    M. P. H. M. Jansen
    K. Ruigrok-Ritstier
    I. L. van Staveren
    M. P. Look
    M. E. Meijer van Gelder
    A. M. Sieuwerts
    S. Sleijfer
    J. A. Foekens
    E. M. J. J. Berns
    [J]. Breast Cancer Research and Treatment, 2011, 125 : 387 - 394
  • [9] Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
    Reijm, E. A.
    Jansen, M. P. H. M.
    Ruigrok-Ritstier, K.
    van Staveren, I. L.
    Look, M. P.
    van Gelder, M. E. Meijer
    Sieuwerts, A. M.
    Sleijfer, S.
    Foekens, J. A.
    Berns, E. M. J. J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 387 - 394
  • [10] The promoter C specific ERα isoform is associated with tamoxifen outcome in breast cancer
    Amaral, Sandra
    Schroth, Werner
    Kugler, Sibylle
    Fritz, Peter
    Simon, Wolfgang
    Brauch, Hiltrud
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) : 323 - 331
12345